- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00172445
Clinical Studies of Kikuchi's Disease
December 6, 2012 updated by: National Taiwan University Hospital
Kikuchi-Fujimoto disease is a distinctive syndrome of necrotizing lymphadenitis which was formally described in 1972 by two Japanese pathologists, Kikuchi and Fujimoto.
It is a benign, self-limited disease that predominantly occurs in young women.
It was more common in Asian people, especially in Japanese.
The most frequent clinical presentations are fever (30~50%) and cervical lymphadenopathy, often tender in palpable.
Other lymph node regions can be affected, and hepatosplenomegaly may be present.
The laboratory findings include leucopenia with atypical lymphocytosis.
ESR, transaminases and lactate dehydrogenase are often raised.
The clinical features are easily confused with other conditions, particularly lymphoma.
Therefore the diagnosis depends on the pathological findings.
The typical findings are paracortical lesions consisting of patchy zones of eosinophilic fibrinoid necrosis and abundant karyorrhexis.
In general, spontaneous resolution of symptoms and signs within a few months can be expected without treatment.For decades, the etiology of Kikuchi's disease has been speculated.
Although the perforin and Fas pathways of cytotoxic T cells induce an abundance of apoptosis and thus induce necrotizing lesions, the trigger factor is unknown.
Since the disease can precede or occur in association with a connective tissue disorder, especially SLE, the autoimmune contribution to the etiology has also been speculated.
However, the clinical course of Kikuchi's disease, often sudden onset and spontaneous resolution, the frequent flu-like or upper respiratory prodrome, and the prominence of cervical lymphadenopathy, support a viral cause.
Evidence for a viral cause also includes peripheral blood atypical lymphocytosis and elevated serum IFN-a or 2'-5' oligoadenylate synthetase levels.
Several infectious agents have been suggested, including bacteria (e.g.
Brucella, Yersinia), parasites (e.g.
toxoplasmosis) and viruses (e.g.
EBV, CMV, HHV6, HHV8, parvovirus B19, HTLV, HIV).The aim of this study is to collect cases of Kikuchi' disease in bureau of NHI and NTUH.
We will analyze the incidence rate, age of onset, sex, season of onset and clinical course to see if there is any clustered cases, or nosocomial infection.
Then we will study the etiology of Kikuchi's disease especially the infection causes by analyzing pathologic specimen and serology.
We hope to find out the etiology of Kikuchi's disease and the new treatment.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Kikuchi's disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
September 12, 2005
First Submitted That Met QC Criteria
September 14, 2005
First Posted (Estimate)
September 15, 2005
Study Record Updates
Last Update Posted (Estimate)
December 10, 2012
Last Update Submitted That Met QC Criteria
December 6, 2012
Last Verified
June 1, 2004
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 9361700760
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lymphadenitis
-
Rabin Medical CenterWithdrawn
-
The Ottawa HospitalWithdrawnBreast Cancer | Axillary LymphadenitisCanada
-
Fahad Javed AwanCompletedTuberculous Lymphadenitis, CervicalPakistan
-
Universitaire Ziekenhuizen KU LeuvenUnknown
-
Far Eastern Memorial HospitalUnknownLymphoma | Kikuchi's DiseaseTaiwan
-
Universitas Katolik Widya Mandala SurabayaIndonesia's Ministry of Research and Technology (Ristekdikti/BRIN)CompletedImmune Defect | Lymphadenitis, TuberculousIndonesia
-
National Taiwan University HospitalRecruitingTuberculous LymphadenitisTaiwan
-
University Hospital, ToulouseRecruiting
-
Tel-Aviv Sourasky Medical CenterUnknownCat-scratch Disease | Bartonella InfectionsIsrael
-
University Medical Centre LjubljanaNot yet recruitingSinusitis | Otitis | Peritonsillar Abscess | Lymphadenitis | Laryngitis | Epiglottitis | Quinsy | Parapharyngeal Abscess | Preseptal Cellulitis | Subperiosteal Abscess | Orbital AbscessSlovenia
Clinical Trials on blood sampling, neck lymph node biopsy
-
University College Hospital GalwayEuropean Respiratory SocietyCompletedLung Cancer Metastatic | Nodes, LungIreland
-
Medizinische Hochschule Brandenburg Theodor FontaneJohann Wolfgang Goethe University HospitalCompleted
-
Radboud University Medical CenterUniversity Medical Center Groningen; Maastricht University Medical Center; UMC... and other collaboratorsRecruitingOropharyngeal Squamous Cell Carcinoma | Laryngeal Squamous Cell Carcinoma | Hypopharynx Squamous Cell CarcinomaNetherlands
-
GlaxoSmithKlineCompleted
-
Duke UniversityCompletedProstate CancerUnited States
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedBreast Neoplasm Female
-
Gangnam Severance HospitalCompletedNeoadjuvant Chemotherapy | Micrometastases
-
University of California, San FranciscoNational Institutes of Health (NIH)Recruiting